Loading paragraph...
Loading chart_type...
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| VRAX | Virax Biolabs Group | $4.36 | -$2.00 | -31.45% | 27.9K | $5.1M | $2.50$28.50 |
| SILO | Silo Pharma | $5.53 | -$2.20 | -28.46% | 264.8K | $8.7M | $3.32$15.15 |
| UBXG | U-bx Technology | $3.42 |
| -$1.21 |
| -26.13% |
| 262.7K |
| $43M |
$2.12$112.50 |
| SDOT | Sadot Group | $21.08 | -$5.63 | -21.08% | 522.2K | $20M | $2.63$460.00 |
| TDTH | Trident Digital Tech | $2.08 | -$0.51 | -19.69% | 361.3K | $9.2M | $1.27$80.40 |
| OPEG | Themes ETF Trust - Leverage Shares 2x Long Open Daily ETF | $4.65 | -$1.01 | -17.82% | 112.8K | - | $3.54$16.86 |
| RBNE | Robin Energy | $6.75 | -$1.28 | -15.97% | 54.7K | $61M | $6.47$374.25 |
| PFSA | Profusa | $2.17 | -$0.37 | -14.57% | 167.4K | $474K | $1.93$10,312.50 |
| DSC | Dsc | $5.93 | -$0.92 | -13.43% | 30.4K | $230M | $4.52$16.35 |
| VRXA | Veraxa Biotech Ag | $2.15 | -$0.33 | -13.30% | 302.5K | $78M | $1.70$27.36 |
| KYTX | Kyverna Therapeutics | $8.53 | -$1.28 | -13.05% | 1.1M | $596M | $2.80$13.67 |
| IOTR | iOThree | $3.29 | -$0.49 | -12.87% | 103.8K | $11M | $1.51$7.47 |
| RGNX | Regenxbio | $13.64 | -$2.01 | -12.84% | 92.4K | $809M | $5.46$16.19 |
| FRMI | Fermi | $6.41 | -$0.92 | -12.50% | 1.8M | $4.7B | $4.47$36.99 |
| PRME | Prime Medicine | $3.71 | -$0.53 | -12.41% | 139.3K | $764M | $2.67$6.94 |
| NKTX | Nkarta | $2.84 | -$0.37 | -11.53% | 814.1K | $230M | $1.70$3.72 |
| ENLV | Enlivex Therapeutics | $6.59 | -$0.81 | -10.95% | 42.4K | $1.8B | $6.42$31.50 |
| JZ | Jianzhi Education Technology Group | $3.51 | -$0.36 | -9.30% | 88.6K | $6.0M | $2.55$98.40 |
| ZSTK | ZeroStack | $2.31 | -$0.18 | -7.23% | 12K | $6.1M | $2.11$47.00 |
Explore the biggest stock losers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock losers and decliners every day with market data, news, and analysis from our Foolish experts.